Additionally, STING activation by CDG promotes IFN production, synergistically inducing a pro-inflammatory phenotype in TAMs and enhancing M1 macrophage-mediated phagocytosis of tumor cells, thereby significantly improving the efficacy of anti-CD47 blockade. Here, STING1 is linked to neoplasm.